Detalle Publicación

ARTÍCULO

Association between individual and combined SNPs in genes related to innate immunity and incidence of CMV infection in seropositive kidney transplant recipients

Autores: Fernández-Ruiz, M.; Corrales, I.; Arias, M.; Campistol, J. M.; Giménez, E.; Crespo, J.; López-Oliva, M. O.; Beneyto, I.; Martín Moreno, Paloma Leticia; Llamas-Fuente, F.; Gutiérrez, A.; García-Álvarez, T.; Guerra-Rodríguez, R.; Calvo, N.; Fernández-Rodríguez, A.; Tabernero-Romo, J. M.; Navarro, M. D.; Ramos-Verde, A.; Aguado, J. M.; Navarro, D.
Título de la revista: AMERICAN JOURNAL OF TRANSPLANTATION (ONLINE)
ISSN: 1600-6143
Volumen: 15
Número: 5
Páginas: 1323 - 1335
Fecha de publicación: 2015
Resumen:
In this study, we assessed the association between single-nucleotide polymorphisms (SNPs) in seven candidate genes involved in orchestrating the immune response against cytomegalovirus (CMV) and the 12-month incidence of CMV infection in 315 CMVseropositive kidney transplant (KT) recipients. Patients were managed either by antiviral prophylaxis or preemptive therapy. CMV infection occurred in 140 patients (44.4%), including 13 episodes of disease. After adjusting for various clinical covariates, patients harboring T-allele genotypes of interleukin-28B (IL28B) (rs12979860) SNP had lower incidence of CMV infection (adjusted hazard ratio [aHR]: 0.66; 95% confidence interval [CI]: 0.46¿0.96; p-value ¿ 0.029). In the analysis restricted to patients not receiving prophylaxis, carriers of the TT genotype of toll-like receptor 9 (TLR9) (rs5743836) SNP had lower incidence of infection (aHR: 0.61; 95% CI: 0.38¿0.96; p-value ¿ 0.035), whereas the GG genotype of dendritic cell-specific ICAM 3-grabbing nonintegrin (DC-SIGN) (rs735240) SNP exerted the opposite effect (aHR: 1.86; 95% CI: 1.18¿2.94; p-value¿ 0.008). An independent association was found between the number of unfavorable SNP genotypes carried by the patient and the incidence of CMV infection. In conclusion, specific SNPs in IL28B, TLR9 and DC-SIGN genes may play a role in modulating the susceptibility to CMV infection in CMV-seropositive KT recipients.